English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, March 18, 2021
Fujitsu Embarks on Joint Research with National Cancer Center Japan to Create New Services for Drug Development and Clinical Trials
富士通、医薬品開発や治験に電子カルテ診療データなどのリアルワールドデータを活用
Tuesday, March 16, 2021
富士通、医薬品の適正使用情報を電子カルテを通じて提供、質の高い医療サービスと患者のQOL向上に貢献
Friday, March 12, 2021
富士通、FJcloudが政府情報システムのためのセキュリティ評価制度(ISMAP)のクラウドサービスリストに登録
理研と富士通、スーパーコンピュータ「富岳」が「第50回 日本産業技術大賞」の最高位「内閣総理大臣賞」を受賞
Thursday, March 11, 2021
富士通と京都大学、AIの推定根拠を説明できる遺伝子変異の病原性推定の検証システムを開発
Fujitsu, Kyoto University Develop Explainable AI Verification System for Estimating Disease-Causing Potential of Genetic Mutations
Wednesday, March 10, 2021
Fujitsu Develops AI Model to Determine Concentration During Tasks Based on Facial Expression
Fujitsu Launches Data-Driven Social Creation Platform in Joint Project with 9 Universities and 2 Research Institutes
Tuesday, March 9, 2021
理研と富士通、スーパーコンピュータ「富岳」完成、共用開始
Fujitsu Ltd Links

https://plus.google.com/+Fujitsu

https://www.facebook.com/FujitsuJapan

https://twitter.com/Fujitsu_Global

https://www.youtube.com/user/FujitsuOfficial

https://www.linkedin.com/company/fujitsu/

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575